|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Joyce JA and Pollard JW:
Microenvironmental regulation of metastasis. Nat Rev Cancer.
9:239–252. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hanahan D and Coussens LM: Accessories to
the crime: Functions of cells recruited to the tumor
microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tommelein J, Verset L, Boterberg T,
Demetter P, Bracke M and De Wever O: Cancer-associated fibroblasts
connect metastasis-promoting communication in colorectal cancer.
Front Oncol. 5:632015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Denys H, Derycke L, Hendrix A, Westbroek
W, Gheldof A, Narine K, Pauwels P, Gespach C, Bracke M and De Wever
O: Differential impact of TGF-beta and EGF on fibroblast
differentiation and invasion reciprocally promotes colon cancer
cell invasion. Cancer Lett. 266:263–274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mishra P, Banerjee D and Ben-Baruch A:
Chemokines at the crossroads of tumor-fibroblast interactions that
promote malignancy. J Leukoc Biol. 89:31–39. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calon A, Espinet E, Palomo-Ponce S,
Tauriello DV, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung
P, Zhang XH, et al: Dependency of colorectal cancer on a
TGF-β-driven program in stromal cells for metastasis initiation.
Cancer Cell. 22:571–584. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hawinkels LJ, Paauwe M, Verspaget HW,
Wiercinska E, van der Zon JM, van der Ploeg K, Koelink PJ, Lindeman
JH, Mesker W, ten Dijke P, et al: Interaction with colon cancer
cells hyperactivates TGF-β signaling in cancer-associated
fibroblasts. Oncogene. 33:97–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taguchi A, Kawana K, Tomio K, Yamashita A,
Isobe Y, Nagasaka K, Koga K, Inoue T, Nishida H, Kojima S, et al:
Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts
(CAFs) is suppressed by omega-3 polyunsaturated fatty acids in
vitro and in vivo. PLoS One. 9:e896052014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brentnall TA: Arousal of cancer-associated
stromal fibroblasts: Palladin-activated fibroblasts promote tumor
invasion. Cell Adhes Migr. 6:488–494. 2012. View Article : Google Scholar
|
|
11
|
Casey TM, Eneman J, Crocker A, White J,
Tessitore J, Stanley M, Harlow S, Bunn JY, Weaver D, Muss H, et al:
Cancer associated fibroblasts stimulated by transforming growth
factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: A
population study. Breast Cancer Res Treat. 110:39–49. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dawes LJ, Eldred JA, Anderson IK, Sleeman
M, Reddan JR, Duncan G and Wormstone IM: TGF beta-induced
contraction is not promoted by fibronectin-fibronectin receptor
interaction, or alpha SMA expression. Invest Ophthalmol Vis Sci.
49:650–661. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kuperwasser C, Chavarria T, Wu M, Magrane
G, Gray JW, Carey L, Richardson A and Weinberg RA: Reconstruction
of functionally normal and malignant human breast tissues in mice.
Proc Natl Acad Sci USA. 101:4966–4971. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ao M, Williams K, Bhowmick NA and Hayward
SW: Transforming growth factor-beta promotes invasion in
tumorigenic but not in nontumorigenic human prostatic epithelial
cells. Cancer Res. 66:8007–8016. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mandelker DL, Yamashita K, Tokumaru Y,
Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim
MS, et al: PGP9.5 promoter methylation is an independent prognostic
factor for esophageal squamous cell carcinoma. Cancer Res.
65:4963–4968. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee YM, Lee JY, Kim MJ, Bae HI, Park JY,
Kim SG and Kim DS: Hypomethylation of the protein gene product 9.5
promoter region in gallbladder cancer and its relationship with
clinicopathological features. Cancer Sci. 97:1205–1210. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ohta T and Fukuda M: Ubiquitin and breast
cancer. Oncogene. 23:2079–2088. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Watanabe T, Kobunai T, Toda E, Kanazawa T,
Kazama Y, Tanaka J, Tanaka T, Yamamoto Y, Hata K, Kojima T, et al:
Gene expression signature and the prediction of ulcerative
colitis-associated colorectal cancer by DNA microarray. Clin Cancer
Res. 13:415–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mizukami H, Shirahata A, Goto T, Sakata M,
Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K:
PGP9.5 methylation as a marker for metastatic colorectal cancer.
Anticancer Res. 28:2697–2700. 2008.PubMed/NCBI
|
|
20
|
Nakagawa H, Liyanarachchi S, Davuluri RV,
Auer H, Martin EW Jr, de la Chapelle A and Frankel WL: Role of
cancer-associated stromal fibroblasts in metastatic colon cancer to
the liver and their expression profiles. Oncogene. 23:7366–7377.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Derynck R and Zhang YE: Smad-dependent and
Smadindependent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sappino AP, Schürch W and Gabbiani G:
Differentiation repertoire of fibroblastic cells: Expression of
cytoskeletal proteins as marker of phenotypic modulations. Lab
Invest. 63:144–161. 1990.PubMed/NCBI
|
|
23
|
Calon A, Tauriello DV and Batlle E:
TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer
Biol. 25:15–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamazaki T, Hibi K, Takase T, Tezel E,
Nakayama H, Kasai Y, Ito K, Akiyama S, Nagasaka T and Nakao A:
PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res.
8:192–195. 2002.PubMed/NCBI
|
|
25
|
Akishima-Fukasawa Y, Ino Y, Nakanishi Y,
Miura A, Moriya Y, Kondo T, Kanai Y and Hirohashi S: Significance
of PGP9.5 expression in cancer-associated fibroblasts for prognosis
of colorectal carcinoma. Am J Clin Pathol. 134:71–79. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim HJ, Kim YM, Lim S, Nam YK, Jeong J,
Kim HJ and Lee KJ: Ubiquitin C-terminal hydrolase-L1 is a key
regulator of tumor cell invasion and metastasis. Oncogene.
28:117–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kabuta T, Mitsui T, Takahashi M, Fujiwara
Y, Kabuta C, Konya C, Tsuchiya Y, Hatanaka Y, Uchida K, Hohjoh H,
et al: Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel
potentiator of cyclin-dependent kinases to enhance cell
proliferation independently of its hydrolase activity. J Biol Chem.
288:12615–12626. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hussain S, Foreman O, Perkins SL, Witzig
TE, Miles RR, van Deursen J and Galardy PJ: The de-ubiquitinase
UCH-L1 is an oncogene that drives the development of lymphoma in
vivo by deregulating PHLPP1 and Akt signaling. Leukemia.
24:1641–1655. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bheda A, Yue W, Gullapalli A, Whitehurst
C, Liu R, Pagano JS and Shackelford J: Positive reciprocal
regulation of ubiquitin C-terminal hydrolase L1 and
beta-catenin/TCF signaling. PLoS One. 4:e59552009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu J, Tao Q, Cheung KF, Jin H, Poon FF,
Wang X, Li H, Cheng YY, Röcken C, Ebert MP, et al: Epigenetic
identification of ubiquitin carboxyl-terminal hydrolase L1 as a
functional tumor suppressor and biomarker for hepatocellular
carcinoma and other digestive tumors. Hepatology. 48:508–518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gonzalez-Zubeldia I, Dotor J, Redrado M,
Bleau AM, Manrique I, de Aberasturi AL, Villalba M and Calvo A:
Co-migration of colon cancer cells and CAFs induced by
TGFβ1 enhances liver metastasis. Cell Tissue Res.
359:829–839. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guido C, Whitaker-Menezes D, Capparelli C,
Balliet R, Lin Z, Pestell RG, Howell A, Aquila S, Andò S,
Martinez-Outschoorn U, et al: Metabolic reprogramming of
cancer-associated fibroblasts by TGF-β drives tumor growth:
Connecting TGF-β signaling with ‘Warburg-like’ cancer metabolism
and L-lactate production. Cell Cycle. 11:3019–3035. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yeung TL, Leung CS, Wong KK, Samimi G,
Thompson MS, Liu J, Zaid TM, Ghosh S, Birrer MJ and Mok SC: TGF-β
modulates ovarian cancer invasion by upregulating CAF-derived
versican in the tumor microenvironment. Cancer Res. 73:5016–5028.
2013. View Article : Google Scholar : PubMed/NCBI
|
